In animal models, hyperosmolar agents like mannitol transiently disrupt the blood-brain barrier (BBB). Does anyone know of similar methods for BBB disruption in in vitro models, particularly in transwell systems?

Any suggestions on protocols or alternative agents would be helpful!

Similar questions and discussions